麻豆传媒

Randy Dotinga

Randy Dotinga

Authors >

Randy Dotinga

Randy Dotinga has been a full-time freelance journalist for more than 20 years. He writes about medicine/science, history, books, and the odd & unusual. His clients range from The Washington Post, The Christian Science Monitor, and dozens of medical trade publications to CrimeReads and Noir City Magazine, a journal about film noir. He is former president of the American Society of Journalists & Authors.

Connect:

email image

Latest from Randy Dotinga

A woman in operating theater ready for glaucoma surgery.

Complete Success Rate Not as High as Expected With Gel Stent Implant for Glaucoma

Furthermore, re-operations, bleb needling were needed in 28% and 18% of patients

DDW over a photo of the Walter E. Washington Convention Center in Washington, DC

Increase in CRC Cases in Younger Age Groups Extends to Preteens

While cases remain rare in younger people, they're much more common than 25 years ago

DDW over a photo of the Walter E. Washington Convention Center in Washington, DC

Gallbladder Cancer Rates Stable or Down, Except in Black Patients

Black patients "presenting more often, and they're presenting at a later stage," researcher says

DDW over a photo of the Walter E. Washington Convention Center in Washington, DC

GLP-2 Analog Reduces Need for Parenteral Support in Patients With Rare GI Condition

Better outcomes in short bowel syndrome and intestinal failure with apraglutide vs placebo

A photo of a bottle of low-dose aspirin tablets spilled onto a plate.

Daily Low-Dose Aspirin Fails to Prevent AMD in Older Adults

However, aspirin was only given for 3 years, "a relatively short" time in the evolution of AMD

ATS over a photo of San Diego Convention Center

Anti-Epilepsy Drug Improves Sleep Apnea Symptoms in Mid-Stage Trial

AHI dipped by as much as 40% in patients who took sulthiame, but CPAP is still the gold standard

ATS over a photo of San Diego Convention Center

Two Antibiotic Regimens Are Effective for M. Xenopi Pulmonary Infections

Patients benefited from clarithromycin or moxifloxacin plus rifampin/ethambutol

ATS over a photo of San Diego Convention Center

Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial

An open-label extension trial of pamrevlumab was cancelled due to these results

ATS over a photo of San Diego Convention Center

Novel Drugs for IPF Improve Lung Function in Mid-Stage Trials

"These are among the two most exciting sets of results we've seen," researcher says

ATS over a photo of San Diego Convention Center

Lung Function Tests: End of Racial Adjustments Could Have Wide Impact

Millions in the U.S. may be reclassified, changing work eligibility, disability compensation

3

鈥�